Last Updated: May 25, 2021    


Research Featured

Excision BioTherapeutics Has Secured $60M to Proceed with HIV Clinical Trial 

Philadelphia magazine | March 5, 2021

Antibody Infusions Prevent Acquisition of Some HIV Strains, NIH Studies Find | January 26, 2021

Resources from 2020 Conference on Retroviruses and Opportunistic Infections

CROI 2020

HIV postexposure prophylaxis-in-pocket: long-term follow-up of individuals with low-frequency, high-risk HIV exposures

AIDS 2020, 34:433–437

Prevention of HIV for persons with low-frequency, high-risk exposures: PrEP (preexposure prophylaxis), PEP (postexposure prophylaxis), or ‘PIP’ (postexposure prophylaxis in-pocket)

AIDS 2020, 34:481–482

News Updates

Combination Immunotherapy Provides Potential Benefits in Controlling, Reducing HIV 

Pharmacy Times | May 19, 2021

Awareness and acceptability of HIV pre-exposure prophylaxis (PrEP) among students at two historically Black universities (HBCU): a cross-sectional survey 

BMC Public Health. 2021 May 19;21(1):943. doi: 10.1186/s12889-021-10996-

New Vaccine Approaches Show Early Promise for HIV 

POZ | May 18, 2019

Investigators Build List of Cells Most Susceptible to HIV Infection 

Pharmacy Times | May 6, 2021

The four-decade quest for an HIV vaccine yields new hope 

National Geographic | May 3, 2021

Scientists identify blood cells most likely to be targeted by HIV during a real-life infection | April 28, 2021

Moderna's mRNA technology could help in the decades-long search for an HIV vaccine 

Business Insider | April 19, 2021

First Human Trial of HIV Vaccine Produced Immune Response in 97% of Volunteers 

Good News Network | April 17, 2021

Rollins Dean Curran to Leave Emory, Announced as 2021 Oxford Commencement Speaker 

The Emory Wheel | April 17, 2021

MHRP launches trial to evaluate IL-15 Agonist as therapy to reduce HIV reservoir 

EurekAlert | April 8, 2021

Researchers devise more efficient, enduring CAR gene therapy to combat HIV 

EurekAlert | April 1, 2021

Researchers devise more efficient, enduring CAR gene therapy to combat HIV 

UCLA Newsroom | April 1, 2021

Fighting HIV: could antibodies be the answer? 

Drug Target Review | March 31, 2021

Results of 'truly disappointing' HIV vaccine trial published 

Healio | March 24, 2021

mRNA vaccine protects monkeys against HIV-like virus 

aidsmap | March 11, 2021

Researchers boost potency of an HIV-1 antibody, tracing new pathways for vaccine development 

EurekAlert | March 11, 2021

Federal funding allocation on HIV/AIDS research in the United States (2008-2018): an exploratory study using Big Data

DocWire News | March 8, 2021

US study suggests women living with HIV should be screened earlier for non-AIDS co-morbidities 

aidsmap | March 1, 2021

A high prevalence of potential HIV elite controllers identified over 30 years in Democratic Republic of Congo 

EBioMedicine. 2021 Feb 20;103258. doi: 10.1016/j.ebiom.2021.103258.

French researchers set for HIV vaccine trials using dendritic cells 

RFI | February 26, 2021

HIV-positive people with severe immunosuppression, APOE4 gene may have increased risk for dementia | February 22, 2021

Argentinian woman has been off HIV treatment for 12 years 

aidsmap | February 18, 2021

Therapeutic potential of HIV-1 entry inhibitor peptidomimetics 

Exp Biol Med (Maywood). 2021 Feb 17;1535370221990870. doi: 10.1177/1535370221990870

How activists pushed to include people with HIV in COVID-19 vaccine trials 

ABC News | February 15, 2021

HIV research yields potential drug target 

EurekAlert | February 10, 2021

Early Progression and Immune Reconstitution Inflammatory Syndrome During Treatment of Mild-To-Moderate Kaposi Sarcoma in Sub-Saharan Africa and South America: Incidence, Long-Term Outcomes, and Effects of Early Chemotherapy 

J Acquir Immune Defic Syndr. 2020 Aug 1;84(4):422-429. doi: 10.1097/QAI.0000000000002361.

Novel HIV vaccine approach shows promise in “landmark” first-in-human trial 

European Pharmaceutical Review | February 5, 2021

Phase IIb AMP Studies: In Vitro Susceptibility of HIV-1 Isolates to Broadly Neutralizing Antibody VRC01 Predicts HIV Prevention Efficacy in MSM, Transgender Persons, and Cisgender Women

Clinical Care Options | February 4, 2021

Islatravir Once Monthly for PrEP Demonstrates Favorable Safety/Tolerability and Meets Pharmacokinetic Threshold Target in Blinded Interim Analysis of Phase IIa Trial

Clinical Care Options | February 4, 2021

The Buenos Aires patient: Argentinian woman controls HIV for at least 12 years after stopping treatment

aidsmap | February 3, 2021

Multispecies Evaluation of a Long-Acting Tenofovir Alafenamide Subdermal Implant for HIV Prophylaxis 

Front Pharmacol. 2020 Nov 25;11:569373. doi: 10.3389/fphar.2020.569373. eCollection 2020.

‘Gilead Sciences pens early-stage HIV vaccine pact with Gritstone Oncology 

FierceBiotech | February 1, 2021

Labmade antibodies can prevent HIV infection—but only if they match the virus 

Science Magazine | January 26, 2021

Pioneering AIDS researcher and doctor Joseph Sonnabend, 1933-2021 

Thomson Reuters Foundation | January 25, 2021

Emory infectious disease leaders appointed to direct Center for AIDS Research 

Emory News Center | January 19, 2021

Incidence and Clearance of High-Risk HPV in Gay and Bisexual Men 

Infectious Disease Advisor | January 14, 2021

Moderna Pushes Forward With Immunization Development for 3 Infectious Diseases 

Pharmacy Times | January 12, 2021

Study examines attitudes toward long-acting injectable HIV therapy among women 

Science Daily | January 7, 2021

Fiscal Year 2021-2025 NIH Strategic Plan for HIV and HIV-Related Research blog | January 7, 2021

CRISPR Gene-Editing Shows Promise Against HIV 

Managed Healthcare Executive | January 4, 2021

    2019 Archives 2020 Archives